Johns Hopkins Diabetes GuideBrand Names

Treatment of Neuropathic Pain

Nima Khoshnoodi, M.D., Michael Polydefkis, M.D., M.H.S., Brian Pinto, Pharm.D.
Treatment of Neuropathic Pain is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Pregabalin for painful diabetic polyneuropathy (DPN)
  • Duloxetine for painful DPN

NON-FDA APPROVED USES

  • Gabapentin most commonly used non-FDA approved medication for DPN[4].
  • Non FDA-approved DPN pain medications include antidepressants, opiates or opiate-like agents and anti-epileptic medications.
  • Antidepressants include tricyclic antidepressants (amitriptyline, nortriptyline) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine).
  • Antiepileptic medications include gabapentin, valproate, lamotrigine, carbamazepine, oxcarbazepine, phenytoin and lacrosamide.
  • Opiate or opiate-derivative agents include oxycodone, morphine sulfate, hydromorphone, fentanyl and tramadol.
  • Other agents include topical agents (lidocaine cream, lidoderm patches, capsaicin cream), neutriceuticals (Metanx, alpha-lipoic acid) and devices (spinal stimulators, transcutaneous electrical nerve stimulation).

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 29, 2017